Facebook Linkedin Twitter
Inside Precision Medicine Protein Degradation Method Paves a Way for New Cancer Therapies

Protein degradation

Pancreatic cancer, pancreas with PDAC, illustration
News & Features

Protein Degradation Method Paves a Way for New Cancer Therapies

0
Translucent robotic looking hand holding a test tube next to a screen showing code and a digital pill to symbolize the use of AI to develop new protein phase separation drugs
News & Features

Novo Nordisk Inks $1.46B Deal with Neomorph for Molecular Glue Degraders

0
3D Rendering of Antibody Drug Conjugate Molecules
News & Features

BMS Pays $100M Upfront for Antibody Degrader Conjugate from Orum

0
Rapamycin inhibiting protein kinase mTORC1
News & Features

Schreiber’s Magnet Emerges from Stealth to Develop Alternative Molecular Glues 

0
Rapamycin inhibiting protein kinase mTORC1
News & Features

Astellas and PeptiDream Ink $21M Plus Protein Degrader Deal 

0
Asked & Answered column photo
News & Features

Asked and Answered: Taking Protein Degradation to a New Therapeutic Frontier—Outside the Cell

0
Scientific Experiment
News & Features

Blueprint Medicines, Proteovant Therapeutics Collaborate on Novel Targeted Protein Degrader Therapies

0

Related Content

Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.
Inside Precision Medicine